A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression

Nutrition and Cancer

Volumn 63, Issue 3, 2011, Pages 427-434

  Dogukan, Ayhan ^a   Tuzcu, Mehmet ^a   Agca, Can Ali ^a   Gencoglu, Hasan ^a   Sahin, Nurhan ^a   Onderci, Muhittin ^b   Ozercan, Ibrahim Hanifi ^a   Ilhan, Necip ^a   Kucuk, Omer ^c   Sahin, Kazim ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b Veterinary Control and Research Institute   (Turkey)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; BETA CAROTENE; CAROTENOID; CISPLATIN; CREATININE; HEAT SHOCK PROTEIN; LIPID; LYCOPENE; MALONALDEHYDE; PHYTOENE SYNTHASE; PROTEIN BAX; PROTEIN BCL 2; TOCOPHEROL; TOMATO LYCOPENE COMPLEX; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PARENCHYMA; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; TREATMENT DURATION; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; BCL-2-ASSOCIATED X PROTEIN; BETA CAROTENE; BLOOD UREA NITROGEN; CAROTENOIDS; CISPLATIN; DINOPROST; DOWN-REGULATION; HEAT-SHOCK PROTEINS; KIDNEY; LIPID PEROXIDATION; LYCOPERSICON ESCULENTUM; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; TOCOPHEROLS; UP-REGULATION;

LYCOPERSICON ESCULENTUM; RATTUS; RATTUS NORVEGICUS;

EID: 79957560881     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.535958     Document Type: Article

References (54)

1. Safirstein R, Winston J, Goldstein M, Moel D, Dikman S, et al.: Cisplatin nephrotoxicity. Am J Kidney Dis 8, 356-367, 1986. (Pubitemid 17235083)
2. Osanto S, Bukman A, Van Hoek F, Sterk PJ, De Laat JA, et al.: Long-term effects of chemotherapy in patients with testicular cancer. J Clin Oncol 10, 574-579, 1992.
3. Luke DR, Vadiei K, and Lopez-Berestein G: Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 7, 1-7, 1992.
4. Kang DG, Lee AS, Mun YJ, Woo WH, Kim YC, et al.: Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol Pharm Bull 27, 366-370, 2004. (Pubitemid 41685481)
5. Rao NK and Nammi S: Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. BMC Complement Altern Med 6, 17-22, 2006.
6. Kotins MS, Patel P, Menon SN, and Sane RT: Renoprotective effect of Hemidesmus indicus, a herbal drug used in gentamicin-induced renal toxicity. Nephrology 9, 142-147, 2004.
7. Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, et al.: Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 63, 72-82, 2003. (Pubitemid 35463908)
8. Davis CA, Nick HS, and Agarwal A: Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 12, 2683-2690, 2001. (Pubitemid 33115415)
9. Srivastava R, Farookh A, Ahmad N, Misra M, Hasan S, et al.: Evidence for involvement of nitric oxide in cisplatin induced toxicity in rats. Biometals 9, 139-142, 1996. (Pubitemid 26144593)
10. Baek S, Kwon C, Kim J, Woo J, Jung J, et al.: Differential roles of hydrogen peroxides and hydroxyl radical in cisplatin induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 142, 178-186, 2003. (Pubitemid 37260471)
11. Durak I, Ozbek H, Karayvaz M, and Ozturk S: Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs: effects of antioxidant supplementation on the cisplation nephrotoxicity. Drugs Chem Toxicol 25, 1-8, 2002. (Pubitemid 34132348)
12. Ramesh G and Reeves WB: TNF-R mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110, 835-842, 2002.
13. Engineer MS, Brown NS, Ho DH, Newman RA, and Bulger RE: A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats. Toxicology 59, 151-162, 1989. (Pubitemid 19270043)
14. Yao X, Panichpisal K, Kurtzman N, and Nugent K: Cisplatin nephrotoxicity: a review. Am J Med Sci 334, 115-124, 2007. (Pubitemid 47262919)
15. Chirino YI, Hernandez-Pando R, and Pedraza-Chaverri J: Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol 4, 20-29, 2004.
16. Jiang M, Wei Q, Pabla N, Dong G, Wang CY, et al.: Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis, and nephrotoxicity. Biochem Pharmacol 73, 1499-1510, 2007. (Pubitemid 46452592)
17. Chirino YI, Trujillo J, Sánchez-González DJ, Martínez-Martínez CM, Cruz C, et al.: Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol Lett 176, 48-57, 2008. (Pubitemid 50008205)
18. McDowell LR: Comparative aspects to human nutrition: vitamin C, A, and E. In Vitamins in Animal Nutrition. Academic Press, London, UK, pp. 93-131, 1989.
19. DiMascio P, Kaiser S, and Sies S: Lycopene as the most effective biologica carotenoid singlet oxygen quencher. Arch Biochem Biophys 274, 532-538, 1989. (Pubitemid 19261144)
20. Rao AV and Agarwal S: Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review. Nutr Res 19, 305-332, 1999.
21. Agarwal S and Rao AV: Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 33, 981-984, 1998. (Pubitemid 28516475)
22. Kucuk O: Chemoprevention of prostate cancer. Cancer Metast Rev 21, 111-124, 2002.
23. Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, et al.: Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 10, 861-868, 2001. (Pubitemid 32738598)
24. Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, et al.: Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med 227, 881-885, 2002. (Pubitemid 35340342)
25. Al-Majed AA, Abd-Allah AR, Al-Rikabi AC, Al-Shabanah OA, and Mostafa AM: Effect of oral administration of Arabic gum on cisplatin-induced nephrotoxicity in rats. J Biochem Mol Toxicol 17, 146-153, 2003. (Pubitemid 36818189)
26. Shimeda Y, Hirotani Y, Akimoto Y, Shindou K, Ijiri Y, et al.: Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull 28, 1635-1638, 2005. (Pubitemid 41324123)
27. Ajith TA, Usha S, and Nivitha V: Ascorbic acid and alpha-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin Chim Acta 375, 82-86, 2007. (Pubitemid 44584223)
28. Sung MJ, Kim DH, Jung YJ, Kang KP, Lee AS, et al.: Genistein protects the kidney from cisplatin-induced injury. Kidney Int 74, 1538-1547, 2008.
29. Koyner JL, Sher Ali R, and Murray PT: Antioxidants: do they have a place in the prevention or therapy of acute kidney injury? Nephron Exp Nephrol 109, 109-117, 2008.
30. Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, and Karaoglu A: Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology 212, 116-123, 2005. (Pubitemid 40981968)
31. Sendão MC, Behling EB, dos Santos RA, Antunes LMG, and Bianchi MLP: Comparative effects of acute and subacute lycopene administration on chromosomal aberrations induced by cisplatin in male rats. Food and Chemical Toxicology 44, 1334-1339, 2006.
32. Karatepe M: Simultaneous determination of ascorbic acid and free malondialdehyde in human serum by HPLC/UV. LC-GC North America 22, 362-365, 2004.
33. Sies H, and Stahl W: Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 62(Suppl 6), S1315-S1321, 1995.
34. Wong YT, Ruan R, and Tay FEH: Relationship between levels of oxidative DNA damage, lipid peroxidation and mitochondrial membrane potential in young and old F344 rats. Free Radic Res 40, 393-402, 2006. (Pubitemid 43336044)
35. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193, 265-275, 1951.
36. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685, 1970.
37. Ross MH, Reith EJ, and Romrell LJ: Histology - A Text and Atlas (ki sp k). Williams and Wilkins, Baltimore, MD, 1989.
38. SAS Institute: SAS User's Guide: Statistics. SAS Institute, Inc., Cary, NC, 1999.
39. Evenepoel P: Acute toxic renal failure. Best Pract Res Clin Anaesthesiol 18, 37-52, 2004.
40. Lameire N, Van Biesen W, and Vanholder R: Acute renal failure. Lancet 365, 417-430, 2005. (Pubitemid 40179230)
41. Sahin K, Ozercan R, Onderci M, Sahin N, Khachik F, et al.: Dietary tomato powder supplementation in the prevention of leiomyoma of the oviduct in the Japanese quail. Nutr Cancer 59, 70-75, 2007. (Pubitemid 47549783)
42. Sahin N, Orhan C, Tuzcu M, Sahin K, and Kucuk O: The effects of tomato powder supplementation on performance and lipid peroxidation in quail. Poult Sci 87, 276-283, 2008. (Pubitemid 351198492)
43. Lee S, Moon SO, Kim W, Sung MJ, Kim DH, et al.: Protective role of L-2-oxothiazolidine-4-carboxylic acid in cisplatin-induced renal injury. Nephrol Dial Transplant 21, 2085-2095, 2006. (Pubitemid 44295033)
44. Böhm F, Tinkler JH, and Truscott TG: Carotenoids protect against cell membrane damage by the nitrogen dioxide radical. Nature Medicine 1, 98-99, 1995.
45. Santos NA, Catão CS, Martins NM, Curti C, Bianchi ML, et al.: Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism, and apoptosis in rat kidney mitochondria. Arch Toxicol 81, 495-504, 2007. (Pubitemid 47012464)
46. Halliwell B: Lipid peroxidation, antioxidants, and cardiovascular disease: how should we move forward? Cardiovasc Res 47, 410-416, 2000.
47. Visioli F, Riso P, Grande S, Gali C, and Porrini M: Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr 42, 201-206, 2003. (Pubitemid 36999072)
48. Jain CK, Agarwal S, and Rao AV: The effect of dietary lycopene on bioavailability, tissue distribution, in vivo antioxidant properties, and colonic preneoplasia in rats. Nutr Res 19, 1383-1391, 1999. (Pubitemid 29409382)
49. Burdon RH: Heat shock and the heat shock proteins. Biochem J 240, 313-324, 1986.
50. Komatsuda, Wakui H, and Imai H: Renal localization of the constitutive 73-kDa heat-shock protein in normal and PAN rats. Kidney Int 41, 1204-1212, 1992.
51. Komatsuda A, Wakui H, Oyama Y, Imai H, and Miura A: Overexpression of the human 72 kDa heat shock protein in renal tubular cells confers resistance against oxidative injury and cisplatin toxicity. Nephrol Dial Transplant 14, 1385-1390, 1999. (Pubitemid 29241727)
52. Stacchiotti A, Lavazza A, Rezzani R, Borsani E, Rodella L, et al.: Mercuric chloride-induced alterations in stress protein distribution in rat kidney. Histol Histopathol 19, 1209-1218, 2004. (Pubitemid 39386779)
53. Lee KW, Jeong JY, Lim BJ, Chang YK, Lee SJ, et al.: Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Toxicology 257, 137-143, 2009.
54. Okamoto M, Hara I, Miyake H, Hara S, Gotoh A, et al.: Synergistic antitumor effect of ionomycin and cisplatin against renal cell carcinoma in vitro and in vivo. Urology 57, 188-192, 2001. (Pubitemid 32065854)